6th October 2026, Tuesday

TechPharus

Latest Posts

HealthTech News

  • Pausing certain arthritis drugs after COVID-19 vaccination raises flare risk without improving antibody response
    on October 6, 2026 at 9:00 pm

    For patients with inflammatory arthritis, holding certain disease-modifying antirheumatic drugs (DMARDs), namely select biologic or Janus kinase inhibitor (JAKi) therapies, for two weeks at the time of a supplemental COVID-19 vaccine dose does not enhance humoral immunogenicity, according to a study published online Oct. 5 in JAMA Internal Medicine.

  • HIV treatment has transformed lives in the UK, but stigma lingers
    on October 6, 2026 at 8:40 pm

    Nearly half a century has passed since the first recognized case of AIDS in the U.K. in December 1981. During that time, perceptions of HIV and people living with HIV have been transformed by medical advances and changing cultural attitudes. Yet the stigma created during the early years of the epidemic has proved much harder to leave behind.

  • Sickle cell pain may involve previously unrecognized biological pathways
    on October 6, 2026 at 8:40 pm

    A small pilot study led by a Rutgers researcher has found differences in blood proteins between people experiencing high and low levels of pain from sickle cell disease, findings that may inform research on new treatments and better pain management.

  • Early-onset menopause linked to increased symptoms of anxiety and depression
    on October 6, 2026 at 8:20 pm

    A study by the University of Oulu has found that women who entered menopause earlier than usual reported more symptoms of anxiety and depression than women of the same age who had not yet entered menopause. The work is published in the journal Acta Obstetricia et Gynecologica Scandinavica.

  • PSMA PET/CT-targeted biopsy improves detection of clinically significant prostate cancer
    on October 6, 2026 at 8:00 pm

    PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with negative or inconclusive MRI findings but persistent clinical risk factors. According to new research published in The Journal of Nuclear Medicine, combining the two biopsy approaches is even more effective, nearly doubling the detection rate. This strategy may help physicians identify clinically significant cancers that would otherwise be difficult to detect, while potentially avoiding unnecessary procedures in appropriately selected patients.